溶解性于甲醇:轻微浑浊
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
亚甲基二苯酚 | Bis(2-hydroxyphenyl)methane | 2467-02-9 | C13H12O2 | 200.237 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 1-Hydroxy-2-(4-hydroxybenzyl)-4-(2-hydroxybenzyl)benzene | 34826-62-5 | C20H18O3 | 306.361 |
1-甲氧基-2-[(4-甲氧基苯基)甲基]-苯 | 2,4'-dimethoxydiphenylmethane | 30567-87-4 | C15H16O2 | 228.291 |
—— | 2,4'-dihydroxybenzyl-6,6'-methylenediphenol | 197805-65-5 | C27H24O4 | 412.485 |
—— | 5-(hydroxymethyl)-2,4'-dihydroxydiphenylmethane | 21243-72-1 | C14H14O3 | 230.263 |
2,4'-二羟基二苯甲酮 | 4-[(2-hydroxyphenyl)carbonyl]phenol | 606-12-2 | C13H10O3 | 214.221 |
—— | (2-ethoxy-phenyl)-(4-ethoxy-phenyl)methane | 33451-13-7 | C17H20O2 | 256.345 |
—— | 2-hydroxy-5-salicyl-benzyl alcohol | 21243-73-2 | C14H14O3 | 230.263 |
—— | 2-hydroxy-3-(4-hydroxy-benzyl)-benzyl alcohol | 21243-71-0 | C14H14O3 | 230.263 |
1,3-苯二甲醇,2-羟基-5-[[2-羟基-3,5-二(羟甲基)苯基]甲基]- | (2-hydroxy-3,5-bis-hydroxymethyl-phenyl)-(4-hydroxy-3,5-bis-hydroxymethyl-phenyl)-methane | 103603-77-6 | C17H20O6 | 320.342 |
—— | 2-[[4-[tert-butyl(dimethyl)silyl]oxyphenyl]methyl]phenol | 197805-63-3 | C19H26O2Si | 314.5 |
—— | 2,4'-Diacetoxy-diphenylmethan | 959033-36-4 | C17H16O4 | 284.312 |
—— | 3,3',5,5'-Tetrabrom-2,4'-dihydroxy-diphenylmethan | 91261-00-6 | C13H8Br4O2 | 515.821 |
2,4'-二甲氧基二苯甲酮 | 2,4'-dimethoxybenzophenone | 5449-69-4 | C15H14O3 | 242.274 |
[[2-[4-(环氧乙烷基甲氧基)苄基]苯氧基]甲基]环氧乙烷 | ortho,para-bisphenol F diglycidyl ether | 57469-07-5 | C19H20O4 | 312.365 |
In traditional Asian medicinal systems, preparations of the root and stem bark of Magnolia species are widely used to treat anxiety and other nervous disturbances. The biphenyl-type neolignans honokiol and magnolol are the main constituents of Magnolia bark extracts. In the central nervous system, Magnolia bark preparations that contain honokiol are thought to primarily interact with γ-aminobutyric acid A (GABAA) receptors. However, stress responses inherently involve the noradrenergic system, which has not been investigated in the pharmacological mechanism of honokiol. We present here interactions of honokiol and other synthesized biphenyl-type neolignans and diphenylmethane analogs with the norepinephrine transporter (NET), which is responsible for the synaptic clearance of norepinephrine and the target of many anxiolytics. Of the synthesized compounds, 16 are new chemical entities, which are fully characterized. The 52 compounds tested show mild, non-potent interactions with NET (IC50 > 100 µM). It is thus likely that the observed anxiolytic effects of, e.g., Magnolia preparations, are not due to direct interaction with the noradrenergic system.